Journey Medical Earnings Preview
Portfolio Pulse from Benzinga Insights
Journey Medical (NASDAQ:DERM) is scheduled to release its quarterly earnings report on March 21, 2024, with an expected EPS of $-0.08. The company's past performance shows a history of beating EPS estimates, leading to significant share price movements. Shares are currently trading at $3.79, up 171.01% over the last 52 weeks, indicating a positive outlook from long-term shareholders.
March 20, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Journey Medical is expected to report an EPS of $-0.08 for the upcoming quarter, with a history of beating estimates and positive share price reactions following earnings announcements.
Given Journey Medical's history of beating EPS estimates and the subsequent positive reactions in its share price, there is a strong likelihood of a positive short-term impact on DERM's stock price if the company beats the EPS estimate again and provides positive guidance for the future. The 171.01% increase in share price over the last 52 weeks further supports a bullish outlook among long-term shareholders, which could contribute to positive momentum following the earnings announcement.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100